Aids, Anthrax, And Compulsory Licensing: Has The United States Learned Anything? A Comment On Recent Decisions On The International Intellectual Property Rights Of Pharmaceutical Patents

Abstract

The concern over protection of Intellectual Property has been an issue for over 500 years